Biotech and Pharmaceuticals

New omicron boosters are now available, but it’s unclear how effective they will be
The U.S. authorized the first major makeover of the Covid-19 vaccines this week in an effort to stem an expected tide of infections and hospitalizations this fall. But it’s unclear how much protection the new booster shots will provide. The Food and Drug Administration and the Centers for Disease Control and Prevention cleared the shots […]
Read More
CDC panel recommends new omicron Covid boosters with shots expected to begin next week
Justin Sullivan | Getty Images The Centers for Disease Control and Prevention’s independent committee on vaccines recommended reformulated booster shots that target the latest omicron subvariants. The panel voted 13 to 1 Thursday in favor of the shots after reviewing the available safety and effectiveness data in an almost seven-hour-long meeting. CDC Director Dr. Rochelle […]
Read More
U.S. health officials brace for another fall Covid surge, but with fewer deaths
People walk past a COVID-19 walk up testing site on July 28, 2022 in New York City. Liao Pan | China News Service | Getty Images Fall is on the horizon and public health officials are again bracing for another wave of Covid cases. Over the past two years, fall and winter have brought devastating […]
Read More
FDA authorizes Covid booster shots that target omicron BA.5 variant
A medical staff prepares a booster dose of Pfizer’s coronavirus disease (COVID-19) vaccine are seen at a vaccination centre in Brussels, Belgium, January 5, 2022. Yves Herman | Reuters The Food and Drug Administration authorized Covid booster shots that target the omicron BA.5 subvariant as the U.S. prepares for another surge of infections this fall […]
Read More
Piper Sandler names Illumina a top pick, says genetics company can surge more than 50%
Shares of Illumina can surge more than 50% from here on the back of new product launches, according to Piper Sandler. Analyst David Westenberg named biotech company Illumina a top pick and reiterated his overweight rating on the stock, citing new sequencing products that could drive growth at the company. “We hosted Illumina on our […]
Read More
Pet ‘moms and dads’ are spending more on their furry family, setting these stocks up for growth
The “pandemic pups” you pass on a stroll around the neighborhood have been a huge windfall for the pet industry. But unlike other booms, the inevitable pullback in demand could be eased by two factors unique to this situation. The first is that pets will continue to require food and care, driving future spending. Second, […]
Read More
CDC cautiously optimistic that monkeypox outbreak might be slowing as cases fall in major cities
The Centers for Disease Control and Prevention is cautiously optimistic that the U.S. is slowing the spread of monkeypox, as new cases fall in several major cities. “We’re watching this with cautious optimism, and really hopeful that many of our harm reduction messages and our vaccines are getting out there and working,” CDC Director Dr. […]
Read More
A dog in France has monkeypox, worrying scientists that we won’t be able to eradicate the virus if it spreads to more animals
Monkeypox virus, illustration. Thom Leach | Science Photo Library | Getty Images In 2003, 47 people across six Midwestern states caught monkeypox from pet prairie dogs that were infected after they were housed with rodents imported from Ghana, Africa. Today’s outbreak, which has already infected more than 14,100 people in the U.S. and more than […]
Read More
FDA authorizes emergency use for Novavax Covid-19 vaccine for ages 12 and 17
A box of the Novavax Covid-19 vaccine arranged at a pharmacy in Schwenksville, Pennsylvania, US, on Monday, Aug. 1, 2022. Bloomberg | Bloomberg | Getty Images Biotechnology company Novavax announced on Friday that its Covid-19 vaccine has been authorized for emergency use by the U.S Food and Drug Administration for adolescents between the ages of […]
Read More
‘Window of opportunity’ to stop monkeypox spread could be closing as vaccine rollouts stall
There are growing concerns that a monkeypox vaccination drive could be stalled amid a shortage of supply. Xinhua News Agency | Getty Images Concerns are mounting that the window of opportunity for containing the escalating monkeypox outbreak may be closing, with vaccine shortages leaving some at-risk groups waiting weeks to get jabbed. Health professionals have […]
Read More